Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)
Keywords:
Adrenergic beta-Antagonists/therapeutic use
Angiotensin II Type 1 Receptor Blockers/therapeutic use
Antihypertensive Agents/therapeutic use
Atenolol/therapeutic use
Biphenyl Compounds/therapeutic use
Cardiomyopathies/drug therapy
Diastole
Hypertension/drug therapy
Tetrazoles/therapeutic use
Publisher:
Lippincott, Williams & Wilkins
Citation:
Muller-Brunotte R, Kahan T, Lopez B, Edner M, Gonzalez A, Diez J, et al. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). J Hypertens 2007 Sep;25(9):1958-1966.
Files in This Item:
There are no files associated with this item.
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.